α- and β-secretase:: profound changes in Alzheimer's disease

被引:154
|
作者
Tyler, SJ
Dawbarn, D
Wilcock, GK
Allen, SJ [1 ]
机构
[1] Univ Bristol, Bristol Royal Infirm, Mol Neurobiol Unit, URCN Care Elderly, Bristol BS2 8HW, Avon, England
[2] Frenchay Hosp, Dept Care Elderly, Bristol BS16 1LE, Avon, England
关键词
Alzheimer's disease; alpha-secretase; amyloid; apolipoprotein E; beta-secretase; BACE; choline acetyltransferase; TACE;
D O I
10.1016/S0006-291X(02)02635-9
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The amyloid plaque, a neuropathological hallmark of Alzheimer's disease, is produced by the deposition of beta-amyloid (Abeta) peptide, which is cleaved from Amyloid Precursor Protein (APP) by the enzyme beta-secretase. Only small amounts of Abeta form in normal brain; more typically this is precluded by the processing of APP by alpha-secretase. Here, we describe a decrease in alpha-secretase (81% of normal) and a large increase in beta-secretase activity (185%) in sporadic Alzheimer's disease temporal cortex. Since alpha-secretase is present principally in neurons known to be vulnerable in Alzheimer's disease, and there is known competition between alpha- and beta-secretase for the substrate APP, it is significant that the majority of Alzheimer samples tested here were low in a-secretase. Eighty percent of Alzheimer brains examined had an increase in beta-secretase, a decrease in alpha-secretase, or both; which may account for the means by which the majority of people develop Alzheimer's disease. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:373 / 376
页数:4
相关论文
共 50 条
  • [41] Secretase inhibitors for the treatment of Alzheimer's disease: Long road ahead
    Kumar, Devendra
    Ganeshpurkar, Ankit
    Kumar, Dileep
    Modi, Gyan
    Gupta, Sanjeev Kumar
    Singh, Sushil Kumar
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2018, 148 : 436 - 452
  • [42] Cerebrospinal Fluid and Serum Beta Secretase Activities in Alzheimer's Disease
    Yaka, Erdem
    Genc, Sermin
    Iyilikci, Leyla
    Yener, Goersev
    JOURNAL OF NEUROLOGICAL SCIENCES-TURKISH, 2010, 27 (01): : 69 - 74
  • [43] Characterization of plasma β-secretase (BACE1) activity and soluble amyloid precursor proteins as potential biomarkers for Alzheimer's disease
    Wu, Guoxin
    Sankaranarayanan, Sethu
    Wong, Jacky
    Tugusheva, Katherine
    Michener, Maria S.
    Shi, Xiaoping
    Cook, Jacquelynn J.
    Simon, Adam J.
    Savage, Mary J.
    JOURNAL OF NEUROSCIENCE RESEARCH, 2012, 90 (12) : 2247 - 2258
  • [44] Turning the tide on Alzheimer's disease: modulation of γ-secretase
    Luo, Joanna E.
    Li, Yue-Ming
    CELL AND BIOSCIENCE, 2022, 12 (01)
  • [45] Delta Secretase and BDNF Signalling in Alzheimer's Disease
    Unlu, Buse
    Ildiz, Sumeyra
    Ak, Duygu Gezen
    Dursun, Erdinc
    EXPERIMED, 2023, 13 (01): : 1 - 7
  • [46] γ-Secretase as a target for drug intervention in Alzheimer's disease
    Harrison, T
    Churcher, I
    Beher, D
    CURRENT OPINION IN DRUG DISCOVERY & DEVELOPMENT, 2004, 7 (05) : 709 - 719
  • [47] Turning the tide on Alzheimer’s disease: modulation of γ-secretase
    Joanna E. Luo
    Yue-Ming Li
    Cell & Bioscience, 12
  • [48] Longitudinal Changes of CSF Biomarkers in Alzheimer's Disease
    Seppala, Toni T.
    Koivisto, Anne M.
    Hartikainen, Paivi
    Helisalmi, Seppo
    Soininen, Hilkka
    Herukka, Sanna-Kaisa
    JOURNAL OF ALZHEIMERS DISEASE, 2011, 25 (04) : 583 - 594
  • [49] Processive proteolysis by γ-secretase and the mechanism of Alzheimer's disease
    Wolfe, Michael S.
    BIOLOGICAL CHEMISTRY, 2012, 393 (09) : 899 - 905
  • [50] Selective Secretase Targeting for Alzheimer's Disease Therapy
    Miranda, Alvaro
    Montiel, Enrique
    Ulrich, Henning
    Paz, Cristian
    JOURNAL OF ALZHEIMERS DISEASE, 2021, 81 (01) : 1 - 17